BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32227396)

  • 1. Diagnostic performance of Mac-2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups.
    Nah EH; Cho S; Kim S; Kim HS; Cho HI
    J Clin Lab Anal; 2020 Aug; 34(8):e23316. PubMed ID: 32227396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection.
    Mak LY; Wong DK; Seto WK; Ning Q; Cheung KS; Fung J; Lai CL; Yuen MF
    Hepatol Int; 2019 Mar; 13(2):148-156. PubMed ID: 30671807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
    Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
    BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia.
    Yamada N; Sanada Y; Tashiro M; Hirata Y; Okada N; Ihara Y; Urahashi T; Mizuta K
    J Gastroenterol; 2017 Feb; 52(2):245-252. PubMed ID: 27349650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.
    Saleh SA; Salama MM; Alhusseini MM; Mohamed GA
    World J Gastroenterol; 2020 Jun; 26(21):2864-2876. PubMed ID: 32550761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection.
    Mak LY; Wong DK; Cheung KS; Seto WK; Lai CL; Yuen MF
    Clin Transl Gastroenterol; 2018 Jun; 9(6):163. PubMed ID: 29915243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of serum Mac-2-binding protein (M2BPGi) during regular follow-up of patients with biliary atresia.
    Ueno T; Kodama T; Noguchi Y; Saka R; Takama Y; Tazuke Y; Bessho K; Okuyama H
    Pediatr Surg Int; 2018 Oct; 34(10):1065-1071. PubMed ID: 30128700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients.
    Sulaiman AS; Hasan I; Lesmana CRA; Kurniawan J; Jasirwan COM; Nababan S; Kalista KF; Hanifa RS; Rachmani D; Gani RA
    Acta Med Indones; 2022 Oct; 54(4):567-573. PubMed ID: 36624717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
    Yamada N; Katano T; Hirata Y; Okada N; Sanada Y; Ihara Y; Urahashi T; Ushijima K; Karasawa T; Takahashi M; Mizuta K
    J Gastroenterol Hepatol; 2019 Feb; 34(2):418-424. PubMed ID: 30101431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases.
    Moon HW; Park M; Hur M; Kim H; Choe WH; Yun YM
    Ann Lab Med; 2018 Jul; 38(4):331-337. PubMed ID: 29611383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B.
    Noguchi R; Kaji K; Namisaki T; Moriya K; Kitade M; Takeda K; Kawaratani H; Okura Y; Aihara Y; Furukawa M; Mitoro A; Yoshiji H
    World J Gastroenterol; 2017 Sep; 23(36):6705-6714. PubMed ID: 29085215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B Patients.
    Jekarl DW; Choi H; Lee S; Kwon JH; Lee SW; Yu H; Kim M; Kim Y; Sung PS; Yoon SK
    Ann Lab Med; 2018 Jul; 38(4):348-354. PubMed ID: 29611385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of liver fibrosis with serum Mac-2 binding protein glycosylation-modified isomer (M2BPGi) during follow-up intestinal failure patients without intestinal failure-associated liver disease (IFALD).
    Ueno T; Takase K; Deguchi K; Masahata K; Nomura M; Watanabe M; Kamiyama M; Tazuke Y; Bessho K; Okuyama H
    Pediatr Surg Int; 2022 Dec; 38(12):1807-1813. PubMed ID: 36125546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of Mac-2-binding protein glycosylation isomer (M2BPGi) as a liver fibrosis marker in chronic hepatitis C patients with chronic kidney disease on hemodialysis.
    Sulaiman AS; Hasan I; Hustrini NM; Lydia A; Hanifa RS; Gani RA
    Clin Exp Nephrol; 2023 Jun; 27(6):557-564. PubMed ID: 36995542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.
    Park HS; Choe WH; Han HS; Yu MH; Kim YJ; Jung SI; Kim JH; Kwon SY
    World J Gastroenterol; 2019 Jul; 25(25):3256-3267. PubMed ID: 31333316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposal of a Novel Serological Algorithm Combining FIB-4 and Serum M2BPGi for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.
    Moon SY; Baek YH; Jang SY; Jun DW; Yoon KT; Cho YY; Jo HG; Jo AJ
    Gut Liver; 2024 Mar; 18(2):283-293. PubMed ID: 37574956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.
    Mak LY; Wong DK; Cheung KS; Hui RW; Liu F; Fung J; Seto WK; Yuen MF
    Dig Dis Sci; 2022 Nov; 67(11):5127-5136. PubMed ID: 35258755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical usefulness of Mac-2 binding protein glycosylation isomer for diagnosing liver cirrhosis and significant fibrosis in patients with chronic liver disease: A retrospective single-center study.
    Park HJ; Seo KI; Lee SU; Han BH; Yun BC; Park ET; Lee J; Hwang H; Yoon M
    Medicine (Baltimore); 2022 Oct; 101(40):e30489. PubMed ID: 36221351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
    Mak LY; To WP; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
    World J Gastroenterol; 2019 Mar; 25(11):1398-1408. PubMed ID: 30918432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Mac-2 Binding Protein Glycosylation Isomer for Prediction of Posthepatectomy Liver Failure in Patients With Hepatocellular Carcinoma.
    Okuda Y; Taura K; Yoshino K; Ikeno Y; Nishio T; Yamamoto G; Tanabe K; Koyama Y; Hatano E; Tanaka S; Uemoto S
    Ann Surg; 2017 Jun; 265(6):1201-1208. PubMed ID: 27355265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.